Dr. Kamran Ijaz Muhammad, MD

Dr. Muhammad practices at Hillcrest Medical Center in Tulsa, Oklahoma, part of Ardent Health.

Dr. Muhammad's NPI, 1164406906, was assigned on December 5, 2005. Dr. Muhammad graduated from University of Massachusetts Medical School in 2002. Dr. Muhammad holds Oklahoma license 28265.

Dr. Muhammad's primary practice is Hillcrest Medical Center, at 1120 South Utica Avenue, Tulsa, OK 74104 in Tulsa County. The practice phone is (918) 579-1000.

Dr. Muhammad's primary practice is Hillcrest Medical Center in Tulsa, Oklahoma, part of Ardent Health. Dr. Muhammad is also affiliated with Hillcrest Hospital South. The medical group on file is Oklahoma Heart Institute. Dmand AI also links Dr. Muhammad to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muhammad practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Muhammad's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Muhammad is licensed in Oklahoma.

CMS data shows 1,038 Medicare services from Dr. Muhammad across 16 procedure codes in 2024, for 419 Medicare patients. Medicare paid $172,153 for them.

CMS counts 419 Medicare patients who saw Dr. Muhammad in 2024. The largest group is 75 to 84, with 209 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muhammad's median patient age at 76, with 47% women.

In 2024, Dr. Muhammad wrote 1,438 Medicare Part D claims for 260 patients. 80% of them were for generic drugs. CMS names the drug for 1,353 of them, across 25 drugs with 11 or more claims each, at $315,499 in total drug cost. In 2023, CMS named 1,258 claims across 27 drugs.

Dr. Muhammad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of coronary angioplasty and stenting by Dr. Muhammad, more than 37% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Muhammad, published from 2011 to 2023. The most frequent topics are Transcatheter Aortic Valve Replacement, Angioplasty, Balloon, Coronary and Aortic Valve. Dr. Muhammad has published most often in JACC Cardiovasc Interv. Dr. Muhammad's most frequent co-authors are Vasilis C. Babaliaros, MD, Adam B. Greenbaum, MD and Robert Anthony Leonardi, MD.

Dmand AI links Dr. Muhammad to 4 clinical trials. 4 are still active or recruiting. Conditions studied include Mitral Valve Insufficiency, Heart Valve Diseases and Mitral Valve Stenosis.

CMS Open Payments shows 1,872 general payments to Dr. Muhammad from 36 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Edwards Lifesciences Corporation paid the most, $1,208,566. It also lists 1 research payment totaling $17 in 2023.

Dr. Muhammad graduated from University of Massachusetts Medical School in 2002.